| Echo Cardiovascular
Abnormality |
PATIENTS
n (%) |
CONTROLS
n (%) |
χ2 y |
p-value |
| Left Atrial Dilatation (LAD) |
11 (45.8) |
2 (8.3) |
6.75 |
0.01* |
| Left Ventricular Dilatation (LVD) |
10 (41.7) |
1 (4.2) |
7.55 |
0.01* |
| LV Systolic dysfunction |
2 (8.3) |
0 (0.0) |
0.52 |
0.47 |
| LV Diastolic dysfunction |
9 (37.5) |
0 (0.0) |
8.75 |
<0.01* |
| Increased aortic root diameter |
7 (29.2) |
2 (8.3) |
2.19 |
0.14 |
| Left Ventricular hypertrophy (LVH)
Concentric LVH
Eccentric LVH
Concentric remodeling |
12 (50.0)
4 (16.7)
8 (33.3)
3 (12.5) |
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0) |
13.44
2.46
7.35
1.42 |
<0.01*
0.12
0.01*
0.23 |
| Thickened Mitral valve leaflets |
3 (12.5) |
0 (0.0) |
1.42 |
0.23 |
| Thickened Tricuspid valve leaflets |
3 (12.5) |
0 (0.0) |
1.42 |
0.23 |
| Thickened Aortic valve cusps |
1 (4.2) |
0 (0.0) |
0.00 |
1.00 |
| Thickened Pericardium |
3 (12.5) |
0 (0.0) |
1.42 |
0.23 |
| Pericardial effusion |
4 (16.7) |
0 (0.0) |
2.46 |
0.12 |
* = Significant